Therapeutic Options in Patients with Barrett’s Esophagus
- 1 July 1999
- journal article
- review article
- Published by S. Karger AG in Digestive Diseases
- Vol. 17 (3) , 145-152
- https://doi.org/10.1159/000016919
Abstract
The rising incidence of esophageal adenocarcinoma has focused attention on the only known risk factor: Barrett’s esophagus. Practice guidelines for the diagnosis, surveillance and management of Barrett’s esophagus were published recently. Although the ultimate goal in the management of this premalignant condition would be the permanent elimination of Barrett’s mucosa, current therapeutic options are limited or still in the investigational stages. This review summarizes current medical and surgical treatment options and introduces endoscopic ablative modalities currently under investigation.Keywords
This publication has 7 references indexed in Scilit:
- Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulationAmerican Journal of Gastroenterology, 1998
- Ultrasonic epithelial ablation of the lower esophagus without stricture formationSurgical Endoscopy, 1998
- Treatment of Barrett's Esophagus by Endoscopic Laser Ablation and Antireflux SurgeryAnnals of Surgery, 1998
- Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IXThe Lancet, 1996
- Barrett's Esophagus with High-Grade DysplasiaAnnals of Surgery, 1996
- The Rationale for Esophagectomy as the Optimal Therapy for Barrett's Esophagus with High-Grade DysplasiaAnnals of Surgery, 1996
- Prevalence of metaplasia at the gastro-oesophageal junctionThe Lancet, 1994